Immune thrombocytopenic purpura and Guillain-Barré syndrome after 23-valent pneumococcal polysaccharide vaccination in Japan: The vaccine effectiveness, networking, and universal safety (VENUS) study
- Resource Type
- Short Communication
- Source
- In
Vaccine 1 January 2024 42(1):4-7 - Subject
- Language
- ISSN
- 0264-410X